Goodwin advised Mercy BioAnalytics, Inc. on the deal. Mercy BioAnalytics, Inc. announced its $41 million Series A financing round. The financing was led by Novalis LifeSciences, with...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here